Stella Xu's most recent trade in Design Therapeutics Inc was a trade of 15,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 31, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Design Therapeutics Inc | Stella Xu | Director | 31 May 2023 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | ||
| Design Therapeutics Inc | Stella Xu | Director | 15 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | ||
| Design Therapeutics Inc | Stella Xu | Director | 18 Mar 2022 | 552,225 | 4,168,605 | - | 19.0 | 10,514,364 | Common Stock | |
| Design Therapeutics Inc | Stella Xu | Director | 18 Mar 2022 | 24,000 | 4,131,405 | - | 19.0 | 456,240 | Common Stock | |
| Design Therapeutics Inc | Stella Xu | Director | 18 Mar 2022 | 13,200 | 4,155,405 | - | 20.3 | 268,488 | Common Stock | |
| Design Therapeutics Inc | Stella Xu | Director | 18 Mar 2022 | 1,455 | 4,129,950 | - | 18.6 | 27,105 | Common Stock | |
| Tempest Therapeutics Inc | Stella Xu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 6,635 | 6,635 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Stella Xu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 579,710 | 579,710 | - | - | Common Stock | |
| Nextcure Inc | Stella Xu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 14,250 | 14,250 | - | - | Stock Option (Right to Buy) | |
| Design Therapeutics Inc | Stella Xu | Director, Ten Percent Owner | 30 Mar 2021 | 7,236,938 | 0 | - | - | Series A Preferred Stock | ||
| Design Therapeutics Inc | Stella Xu | Director, Ten Percent Owner | 30 Mar 2021 | 4,439,839 | 4,439,839 | - | - | Common Stock | ||
| Design Therapeutics Inc | Stella Xu | Director, Ten Percent Owner | 30 Mar 2021 | 458,016 | 0 | - | - | Series B Preferred Stock | ||
| Design Therapeutics Inc | Stella Xu | Director, Ten Percent Owner | 30 Mar 2021 | 280,991 | 4,720,830 | - | - | Common Stock | ||
| Design Therapeutics Inc | Stella Xu | Director, Ten Percent Owner | 30 Mar 2021 | 10,000 | 4,730,830 | - | 20 | 200,000 | Common Stock | |
| Design Therapeutics Inc | Stella Xu | Director, Ten Percent Owner | 25 Mar 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) |